These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20942940)

  • 1. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
    Miskowiak KW; Vinberg M; Harmer CJ; Ehrenreich H; Knudsen GM; Macoveanu J; Hansen AR; Paulson OB; Siebner HR; Kessing LV
    Trials; 2010 Oct; 11():97. PubMed ID: 20942940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.
    Miskowiak KW; Vinberg M; Christensen EM; Bukh JD; Harmer CJ; Ehrenreich H; Kessing LV
    Neuropsychopharmacology; 2014 May; 39(6):1399-408. PubMed ID: 24322509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial.
    Miskowiak KW; Ehrenreich H; Christensen EM; Kessing LV; Vinberg M
    J Clin Psychiatry; 2014 Dec; 75(12):1347-55. PubMed ID: 25099079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.
    Petersen JZ; Schmidt LS; Vinberg M; Jørgensen MB; Hageman I; Ehrenreich H; Knudsen GM; Kessing LV; Miskowiak KW
    Trials; 2018 Nov; 19(1):611. PubMed ID: 30400939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural correlates of improved executive function following erythropoietin treatment in mood disorders.
    Miskowiak KW; Vinberg M; Glerup L; Paulson OB; Knudsen GM; Ehrenreich H; Harmer CJ; Kessing LV; Siebner HR; Macoveanu J
    Psychol Med; 2016 Jun; 46(8):1679-91. PubMed ID: 26996196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study.
    Vinberg M; Weikop P; Olsen NV; Kessing LV; Miskowiak K
    Brain Behav Immun; 2016 Oct; 57():53-57. PubMed ID: 27181179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
    Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
    Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cognitive remediation on cognitive dysfunction in partially or fully remitted patients with bipolar disorder: study protocol for a randomized controlled trial.
    Demant KM; Almer GM; Vinberg M; Kessing LV; Miskowiak KW
    Trials; 2013 Nov; 14():378. PubMed ID: 24206639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders.
    Miskowiak KW; Vinberg M; Macoveanu J; Ehrenreich H; Køster N; Inkster B; Paulson OB; Kessing LV; Skimminge A; Siebner HR
    Biol Psychiatry; 2015 Aug; 78(4):270-7. PubMed ID: 25641635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.
    Torrent C; Martinez-Arán A; Daban C; Amann B; Balanzá-Martínez V; del Mar Bonnín C; Cruz N; Franco C; Tabarés-Seisdedos R; Vieta E
    Compr Psychiatry; 2011; 52(6):613-22. PubMed ID: 21295774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of erythropoietin on cognition in affective disorders - Associations with baseline deficits and change in subjective cognitive complaints.
    Ott CV; Vinberg M; Kessing LV; Miskowiak KW
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1264-73. PubMed ID: 27349944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.
    Miskowiak KW; Favaron E; Hafizi S; Inkster B; Goodwin GM; Cowen PJ; Harmer CJ
    Psychopharmacology (Berl); 2009 Nov; 207(1):133-42. PubMed ID: 19705104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales.
    Luckenbaugh DA; Ameli R; Brutsche NE; Zarate CA
    J Psychiatr Res; 2015 Feb; 61():40-5. PubMed ID: 25592045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study.
    Vinberg M; Miskowiak K; Hoejman P; Pedersen M; Kessing LV
    PLoS One; 2015; 10(5):e0127629. PubMed ID: 26011424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.
    Furey ML; Drevets WC
    Arch Gen Psychiatry; 2006 Oct; 63(10):1121-9. PubMed ID: 17015814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin.
    Miskowiak KW; Rush AJ; Gerds TA; Vinberg M; Kessing LV
    J Clin Psychiatry; 2016 Dec; 77(12):e1639-e1646. PubMed ID: 27835716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.
    Young AH; Gallagher P; Watson S; Del-Estal D; Owen BM; Ferrier IN
    Neuropsychopharmacology; 2004 Aug; 29(8):1538-45. PubMed ID: 15127079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls.
    Smith J; Browning M; Conen S; Smallman R; Buchbjerg J; Larsen KG; Olsen CK; Christensen SR; Dawson GR; Deakin JF; Hawkins P; Morris R; Goodwin G; Harmer CJ
    Mol Psychiatry; 2018 May; 23(5):1127-1133. PubMed ID: 28533517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial.
    Macoveanu J; Petersen JZ; Mariegaard J; Jespersen AE; Cramer K; Bruun CF; Madsen HØ; Jørgensen MB; Vinberg M; Fisher PM; Knudsen GM; Hageman I; Ehrenreich H; Kessing LV; Miskowiak KW
    J Psychopharmacol; 2024 Apr; 38(4):362-374. PubMed ID: 38519416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.